The DNA microarray market is witnessing steady growth due to the rising demand for advanced genomic research, personalized medicine, and early disease diagnosis. The increasing prevalence of cancer, ...
The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...
DNA Microarrays have become important in genome-wide expression studies. However, to fully use the power of the microarrays, more sophisticated and user-friendly data management and analysis tools ...
Oligonucleotide microarray (DNA chip)–based hybridization analysis is a promising new technology which potentially allows rapid and cost–effective screens for all possible mutations and sequence ...
Global Market OverviewThe Global Non-Invasive Prenatal Testing (NIPT) Market is projected to expand at a CAGR of 16% by 2029, ...
OGM Can Resolve Previously Unresolved Rare Disease CasesOGM Can Serve as a Gold Standard Technique for Characterization of ...
Illumina () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock hedge fund-level data and powerful investing tools for smart ...
Hosted on MSN
Inside the evolving world of cytogenetics technology
Cytogenetics is rapidly advancing with innovations that merge traditional chromosome analysis with automation, AI, and high-throughput genomic tools. These developments are improving speed, accuracy, ...
Hosted on MSN
Faster, smarter lab diagnostics for better care
From automation to lean process redesign, laboratories worldwide are transforming how they handle diagnostics to deliver faster, more accurate results. These changes address bottlenecks, reduce errors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results